Natsuko Nakagawa Selected Research

Natsuko Nakagawa Research Topics

7	Rheumatoid Arthritis 01/2020 - 01/2007
2	Infections 04/2022 - 05/2013
1	Open Fractures (Compound Fracture) 04/2022
1	Body Weight (Weight, Body) 04/2022
1	Leukemia 01/2018
1	Symptom Flare Up 05/2013
1	Synovitis 12/2011
1	Contracture 01/2008
1	Spontaneous Fractures (Pathological Fracture) 08/2004

2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 01/2009
1	Amikacin (A.M.K)FDA LinkGeneric 04/2022
1	Gentamicins (Gentamicin)FDA LinkGeneric 04/2022
1	AminoglycosidesIBA 04/2022
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 04/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2022
1	Cefazolin (Ancef)FDA LinkGeneric 04/2022
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Abatacept (Orencia)FDA Link 01/2020
1	AlbuminsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	tocilizumab (atlizumab)FDA Link 05/2013

3	Synovectomy 12/2011 - 08/2004
1	Therapeutics 04/2022
1	Orthopedic Procedures 01/2020
1	Perioperative Period 05/2013
1	Conservative Treatment 12/2011
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2008
1	Curettage 08/2004
1	Bone Transplantation (Bone Grafting) 08/2004